Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SITC 2023 | The role of glycoproteomics in cancer progression

Yana Najjar • 6 Nov 2023
SITC 2023
General

Yana Najjar, MD, UPMC Hillman Cancer Center, Pittsburgh, PA, provides an overview of glycoproteomics’ significance in the treatment of cancers. Since most proteins are glycosylated, failing to study them in this respect provides a limited view of their functions; this is relevant to cancer research as glycosylation has been implicated in tumor metastasis and transformation. This interview took place at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Yana Najjar

2:13
Next steps in validating glycosylated proteins as biomarkers for melanoma treatment response
Yana Najjar • 6 Nov 2023
6:05
Glycosylated proteins are predictive of immunotherapy response in metastatic melanoma
Yana Najjar • 6 Nov 2023

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals